Nordson layoffs, on the record
Every job cut, severance charge and restructuring Nordson reported in its annual reports, 2023 to 2025, quoted from the filings. Headcount went from 7,900 to approximately 8,000.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | 7,900 | October 31, 2023 |
| 10-K for 2024 | approximately 8,000 | October 31, 2024 |
| 10-K for 2025 | approximately 8,000 | October 31, 2025 |
Job cuts, severance and restructuring
Our summaryThe company reported fees, severance, and non-cash inventory charges tied to the CyberOptics acquisition, which lowered its operating margin.
Word for word“The 6.1 percentage point decline in operating margin was primarily due to fees, severance, and non-cash inventory charges of $10,295 associated with the CyberOptics acquisition and factory inefficiencies due to reduced volumes.” 10-K for 2023
Our summaryThe company reported severance costs as a driver of lower operating profit in its Industrial Precision Solutions segment.
Word for word“IPS operating profit declined 140 basis points due to an unfavorable acquisition impact and severance costs.” 10-K for 2024
Our summaryThe company reported fees, severance and non-cash inventory charges tied to the Atrion acquisition, which reduced operating margin in its Medical and Fluid Solutions segment.
Word for word“MFS operating margin declined 170 basis points due to $10,761 in fees, severance, and non-cash inventory charges associated with the Atrion acquisition which offset improvements in operating efficiencies.” 10-K for 2024
Our summaryThe company cited cost reduction actions in its Advanced Technology Solutions segment, though the filing does not state their size or cost.
Word for word“ATS operating margin improved by 90 basis points on lower sales volumes due to cost reduction actions and favorable mix.” 10-K for 2024
Our summaryThe company exited its medical contract manufacturing business and recorded a non-cash divestiture charge in 2025.
Word for word“Excluding the non-cash divestiture and related charges of $ 12,545 recorded in 2025, the operating results of the medical contract manufacturing business were not material to our Consolidated Financial Statements for any period presented.” 10-K for 2025
Our summaryOperating profit rose in 2025, but severance and other cost reduction costs increased, as did divestiture charges tied to exiting the medical contract manufacturing business.
Word for word“Consolidated operating profit increased in 2025 compared to 2024 due to the overall increase in segment EBITDA and lower acquisition and related inventory step-up amortization costs partially offset by an increase in severance and other cost reduction costs, depreciation and amortization from recent acquisitions, and divestiture charges associated with the exit of the medical contract manufacturing business.” 10-K for 2025
| Fiscal year ended | Severance costs | Restructuring charges | Cash paid for restructuring |
|---|---|---|---|
| 2016-10-31 | — | $5.2 million | $12.6 million |
| 2017-10-31 | — | $39,000 | $1.2 million |
| 2023-10-31 | −$5.5 million | — | — |
| 2024-10-31 | −$17.3 million | — | — |
| 2025-10-31 | −$19.3 million | — | — |
Nordson has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Nordson’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2025-12-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.